TSOI (Therapeutic Solutions International) ROA %: -109.34% (As of Sep. 2024)


What is Therapeutic Solutions International ROA %?

Therapeutic Solutions International TSOI -99.00% ROA % is -109.34% as of Sep. 2024.

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Therapeutic Solutions International's annualized Net Income for the quarter that ended in Sep. 2024 was $-4.03 Mil. Therapeutic Solutions International's average Total Assets over the quarter that ended in Sep. 2024 was $3.69 Mil. Therefore, Therapeutic Solutions International's annualized ROA % for the quarter that ended in Sep. 2024 was -109.34%.

The historical rank and industry rank for Therapeutic Solutions International's ROA % or its related term are showing as below:

TSOI's ROA % is not ranked *
in the Biotechnology industry.
Industry Median: -32.84
* Ranked among companies with meaningful ROA % only.

Therapeutic Solutions International  (OTCPK:TSOI) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Sep. 2024 )
=Net Income/Total Assets
=-4.032/3.6875
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-4.032 / 0.08)*(0.08 / 3.6875)
=Net Margin %*Asset Turnover
=-5040 %*0.0217
=-109.34 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Therapeutic Solutions International ROA % Related Terms


Therapeutic Solutions International ROA % Historical Data

* Premium members only.

The historical data trend for Therapeutic Solutions International's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therapeutic Solutions International ROA % Chart

Therapeutic Solutions International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -655.21 -481.40 -255.37 -143.33 -62.92

Therapeutic Solutions International Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -69.19 -50.49 -63.76 -39.88 -109.34

TSOI vs BPTH, RGBP, HEPA: ROA % Comparison

For the Biotechnology subindustry, Therapeutic Solutions International's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Therapeutic Solutions International ROA % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Therapeutic Solutions International's ROA % distribution charts can be found below:

* The bar in red indicates where Therapeutic Solutions International's ROA % falls into.



Therapeutic Solutions International ROA % Calculation

Therapeutic Solutions International's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-2.17/( (3.606+3.292)/ 2 )
=-2.17/3.449
=-62.92 %

Therapeutic Solutions International's annualized ROA % for the quarter that ended in Sep. 2024 is calculated as:

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=-4.032/( (3.775+3.6)/ 2 )
=-4.032/3.6875
=-109.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Sep. 2024) net income data. ROA % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROA % →
What does a ROA % of -109.34% mean?
Therapeutic Solutions International (TSOI) has a ROA % of -109.34% as of Sep. 2024. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Therapeutic Solutions International and its competitors.
Is Therapeutic Solutions International's ROA % too high?
Therapeutic Solutions International's current ROA % is -109.34%.
How does Therapeutic Solutions International's ROA % compare to BPTH and RGBP?
Therapeutic Solutions International's ROA % of -109.34% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Biotechnology company?
A good ROA % depends on the Biotechnology industry context. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Therapeutic Solutions International and its competitors. Therapeutic Solutions International's current ROA % is -109.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Therapeutic Solutions International stock overvalued right now?
Therapeutic Solutions International (TSOI) has a current ROA % of -109.34%. The current ROA % is -109.34%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Therapeutic Solutions International (TSOI), the current ROA % is -109.34% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Therapeutic Solutions International Business Description

Address 701 Wild Rose Lane, Elk City, ID, USA, 83525
Therapeutic Solutions International Inc focuses on immune modulation for the treatment of several specific diseases. It is engaged in developing a range of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. The business divisions of the company are Nutraceutical Division which produces nutraceuticals. Its current product, QuadraMune, is a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone. Cellular Division obtained exclusive rights to a patented adult stem cell for the development of therapeutics in the area of chronic traumatic encephalopathy and traumatic brain injury and Lung Pathology.